Literature DB >> 29949170

Oxidative stress as a possible mechanism underlying multi-hormonal deficiency in chronic heart failure.

A Mancini1, E Vergani, C Bruno, G Olivieri, C Di Segni, A Silvestrini, A Venuti, A Favuzzi, E Meucci.   

Abstract

OBJECTIVE: Chronic Heart Failure (CHF) is associated with multi-hormonal derangement depicting a prevalence of catabolic vs. anabolic axes. Moreover, thyroid adaption is characterized by the reduced conversion of thyroxine to the active hormone triiodothyronine. On the other hand, hormones modulate synthesis and utilization of antioxidant systems. Therefore, hormonal failure can cause unbalance between reactive radical species and the defenses, resulting in oxidative stress (OS). OS is well described in CHF, but the relationship with the hormonal picture is not entirely known. In the present review, we firstly analyze the mechanisms of ROS production in the heart, discussing animal and human studies, and focusing on new discovered protective mechanisms such as sirtuins and fibroblast growth factor 21 (FGF21). The second section is dedicated to the role of main anabolic axes influencing antioxidant systems. Finally, we present some data supporting the hypothesis that OS could be the link between hormonal derangement and clinical outcome of CHF.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29949170     DOI: 10.26355/eurrev_201806_15279

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  5 in total

1.  Anabolic Hormones Deficiencies in Heart Failure With Preserved Ejection Fraction: Prevalence and Impact on Antioxidants Levels and Myocardial Dysfunction.

Authors:  Carmine Bruno; Andrea Silvestrini; Rodolfo Calarco; Angela M R Favuzzi; Edoardo Vergani; Maria Anna Nicolazzi; Claudia d'Abate; Elisabetta Meucci; Alvaro Mordente; Raffaele Landolfi; Antonio Mancini
Journal:  Front Endocrinol (Lausanne)       Date:  2020-05-12       Impact factor: 5.555

Review 2.  Oxidative Stress and Low-Grade Inflammation in Polycystic Ovary Syndrome: Controversies and New Insights.

Authors:  Antonio Mancini; Carmine Bruno; Edoardo Vergani; Claudia d'Abate; Elena Giacchi; Andrea Silvestrini
Journal:  Int J Mol Sci       Date:  2021-02-07       Impact factor: 5.923

3.  Tentative exploration of pharmacodynamic substances: Pharmacological effects, chemical compositions, and multi-components pharmacokinetic characteristics of ESZWD in CHF-HKYd rats.

Authors:  Li-Li Hong; Yan Zhao; Wei-Dong Chen; Chen-Yu Yang; Guo-Zhuan Li; Hong-Song Wang; Xiao-Yu Cheng
Journal:  Front Cardiovasc Med       Date:  2022-09-14

Review 4.  Metabolic remodeling induced by mitokines in heart failure.

Authors:  Jiahao Duan; Zijun Chen; Yeshun Wu; Bin Zhu; Ling Yang; Chun Yang
Journal:  Aging (Albany NY)       Date:  2019-09-09       Impact factor: 5.682

5.  Anabolic Hormone Deficiencies in Heart Failure with Reduced or Preserved Ejection Fraction and Correlation with Plasma Total Antioxidant Capacity.

Authors:  Antonio Mancini; Angela Maria Rita Fuvuzzi; Carmine Bruno; Maria Anna Nicolazzi; Edoardo Vergani; Nunzia Ciferri; Andrea Silvestrini; Elisabetta Meucci; Nicola Nicolotti; Roberta D'Assante; Antonio Cittadini
Journal:  Int J Endocrinol       Date:  2020-01-03       Impact factor: 3.257

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.